StockDuty ← Dashboard Oct 20, 2026 12:12 PM ET
SignalFDA/Bio

Alvotech wins FDA nod for new manufacturing process for Humira biosimilar

FDA approval of new manufacturing process for Humira biosimilar.

What happened: The U.S. FDA approved a new manufacturing process for Simlandi, Alvotech's biosimilar to Humira that it markets with Teva Pharmaceutical. Why it matters: Alvotech shares spiked on Tuesday following the approval. Simlandi targets AbbVie's arthritis therapy Humira (adalimumab).
The U.S. FDA approved a new manufacturing process for Simlandi, Alvotech's biosimilar to Humira that it markets with Teva Pharmaceutical.
Alvotech shares spiked on Tuesday following the approval. Simlandi targets AbbVie's arthritis therapy Humira (adalimumab).
Sources